|
AU645243B2
(en)
|
1988-03-18 |
1994-01-13 |
General Hospital Corporation, The |
Human heat shock factor
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
DE69429723T2
(de)
|
1993-06-04 |
2002-09-26 |
Whitehead Institute For Biomedical Research, Cambridge |
Stressproteine und ihre verwendung
|
|
ES2216009T3
(es)
|
1994-03-21 |
2004-10-16 |
Rijksuniversiteit Utrecht |
Fragmentos peptidicos de proteinas de estres microbianas y composicion farmaceutica a base de estos para el tratamiento y la prevencion de enfermedades inflamatorias.
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
HU222994B1
(hu)
|
1995-11-02 |
2004-01-28 |
BIOREX Kutató és Fejlesztő Rt. |
Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
|
|
US5962313A
(en)
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
|
WO1998012208A1
(en)
|
1996-09-20 |
1998-03-26 |
The University Of New Mexico |
Heat shock protein complexes
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
TR200002973T2
(tr)
|
1998-01-23 |
2001-02-21 |
National Jewish Medical And Research Center |
Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesi
|
|
EP1829551B1
(en)
|
1998-02-20 |
2010-09-29 |
University of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
CA2325735C
(en)
|
1998-03-27 |
2013-06-04 |
Gabriele Multhoff |
Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation
|
|
FR2777890B1
(fr)
|
1998-04-22 |
2000-12-29 |
Roussy Inst Gustave |
Composes peptidiques d'hsp70 utiles dans l'immunotherapie du cancer
|
|
US6274597B1
(en)
|
1998-06-01 |
2001-08-14 |
Mount Sinai School Of Medicine Of New York University |
Method of enhancing lysosomal α-Galactosidase A
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
HU226617B1
(en)
|
1998-12-14 |
2009-04-28 |
Cytrx Corp |
Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
|
|
HUP9900475D0
(en)
|
1999-02-26 |
1999-04-28 |
Biorex Kutato Fejlesztoe Kft |
O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
|
|
EP1218030A4
(en)
|
1999-09-10 |
2004-09-15 |
Univ Fordham |
METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF GRAFT REJECTS USING THERMAL SHOCK PROTEINS
|
|
US20020039583A1
(en)
|
1999-09-30 |
2002-04-04 |
Subjeck John R. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US20030236300A1
(en)
|
1999-10-27 |
2003-12-25 |
Yale University |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
AU1582801A
(en)
|
1999-11-05 |
2001-06-06 |
Board Of Regents Of The University Of Nebraska, The |
Methods and compositions for protection against bovine herpesvirus
|
|
US6964851B2
(en)
|
1999-12-07 |
2005-11-15 |
Stressgen Biotechnologies Corp. |
Compositions and methods for detecting stress-inducible proteins
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
US20020127219A1
(en)
|
1999-12-30 |
2002-09-12 |
Okkels Jens Sigurd |
Lysosomal enzymes and lysosomal enzyme activators
|
|
US20010034042A1
(en)
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
WO2001052890A1
(en)
|
2000-01-21 |
2001-07-26 |
University Of Connecticut Health Center |
Heat shock/stress protein complexes as vaccines against neurodegenerative disorders
|
|
WO2001052877A1
(en)
|
2000-01-21 |
2001-07-26 |
University Of Connecticut Health Center |
Compositions and methods to treat neurodegenerative disorders
|
|
HUP0001583A2
(hu)
|
2000-04-18 |
2002-11-28 |
BIOREX Kutató és Fejlesztő Rt. |
Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
|
|
US20020095135A1
(en)
|
2000-06-19 |
2002-07-18 |
David Meeker |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
AU2001277961A1
(en)
|
2000-08-07 |
2002-02-18 |
Antigenics, Llc |
Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
|
|
US7517948B2
(en)
|
2000-09-13 |
2009-04-14 |
Multimmune Gmbh |
Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof
|
|
AU2001292674A1
(en)
|
2000-09-15 |
2002-04-29 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US20020172682A1
(en)
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
|
US20020119163A1
(en)
|
2000-11-03 |
2002-08-29 |
The Board Of Regents Of The University Of Nebraska |
Methods and compositions for protection against bovine viral deseases
|
|
EP1209226A3
(en)
|
2000-11-07 |
2002-06-05 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70)
|
|
US20020142299A1
(en)
|
2001-01-09 |
2002-10-03 |
Davidson Beverly L. |
PTD-modified proteins
|
|
JP2004522763A
(ja)
|
2001-02-20 |
2004-07-29 |
ユーエイビー リサーチ ファンデーション |
リソソーム蓄積症のアミノグリコシド治療
|
|
JP4384489B2
(ja)
|
2001-08-20 |
2009-12-16 |
ユニバーシティー オブ コネティカット ヘルス センター |
癌及び感染性疾患の治療に有用な熱ショックタンパク質又はα−２−マクログロブリンを含む組成物の調製方法
|
|
HU0103939D0
(en)
|
2001-09-27 |
2001-11-28 |
Biorex Kutato Fejlesztoe Kft |
Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
|
|
US20050267020A1
(en)
|
2001-09-27 |
2005-12-01 |
Olivier Faure |
Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
|
|
GB0123756D0
(en)
|
2001-10-03 |
2001-11-21 |
King S College London |
A novel chaperone-type of adjuvant for vaccination - Basic 1
|
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
|
ITMI20012573A1
(it)
|
2001-12-06 |
2003-06-06 |
D B P Dev Biotechonologica L P |
Gli acilsalicilati:una nuova classe di induttori di risposta heat shock
|
|
CN1615296A
(zh)
|
2002-01-11 |
2005-05-11 |
拜奥列克斯研究发展公司 |
甲脒衍生物及其在治疗血管疾病中的用途
|
|
WO2003061684A2
(en)
|
2002-01-24 |
2003-07-31 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Tumour treatment compositions comprising hsp70 and tumour necrosis factor
|
|
CA2476556A1
(en)
|
2002-02-13 |
2003-08-21 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
|
IL148401A0
(en)
|
2002-02-26 |
2002-09-12 |
Hadasit Med Res Service |
Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
|
|
WO2003086452A2
(en)
|
2002-04-05 |
2003-10-23 |
Genzyme Corporation |
Methods of enhancing lysosomal storage disease therapy
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
IL164799A0
(en)
|
2002-04-25 |
2005-12-18 |
Univ Connecticut |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
JP2006507272A
(ja)
|
2002-05-02 |
2006-03-02 |
ユニバーシティー オブ コネティカット ヘルス センター |
熱ショックタンパク質−ペプチド複合体またはα−２−マクログロブリン−ペプチド複合体を含むワクチンに対する免疫応答を増強するための熱ショックタンパク質およびα−２−マクログロブリンの使用
|
|
JP2005533015A
(ja)
|
2002-05-02 |
2005-11-04 |
ユニバーシティー オブ コネティカット ヘルス センター |
抗体療法の有効性を増強するための熱ショックタンパク質の使用
|
|
GB0216414D0
(en)
|
2002-07-15 |
2002-08-21 |
Novartis Ag |
Organic compounds
|
|
EP2444409A2
(en)
|
2002-09-16 |
2012-04-25 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
DK1625148T3
(da)
|
2003-05-21 |
2013-01-14 |
Biotech Tools Sa |
Peptidkompleks
|
|
US7244616B2
(en)
|
2003-06-27 |
2007-07-17 |
Bayer Pharmaceuticals Corporation |
Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
|
|
HUP0303584A3
(en)
*
|
2003-10-30 |
2009-12-28 |
Cytrx Corp |
Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
|
|
ATE493432T1
(de)
|
2003-11-12 |
2011-01-15 |
Alfa Biogene Internat B V |
Gewinnung von hitzeschockproteinen
|
|
CN1897957A
(zh)
|
2003-11-25 |
2007-01-17 |
纽约大学西奈山医学院 |
尼曼－皮克病的基于陪伴分子的治疗
|
|
ES2324538T3
(es)
|
2003-12-05 |
2009-08-10 |
Multimmune Gmbh |
Anticuerpos anti-hsp terapeuticos y de diagnostico.
|
|
US20060009520A1
(en)
|
2004-05-12 |
2006-01-12 |
Tall Alan R |
Retinoid-based methods for altering macrophage cholesterol
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
WO2006062402A2
(en)
|
2004-12-10 |
2006-06-15 |
Zernike Business Support B.V. |
Heat shock proteins (hsp) and supraventricular arrhythmia
|
|
KR20130128481A
(ko)
|
2005-06-08 |
2013-11-26 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
리소좀 효소를 코딩하는 유전자의 돌연변이와 관련있는 ｃｎｓ 질환의 치료 방법
|
|
WO2007041285A2
(en)
|
2005-09-29 |
2007-04-12 |
Viral Genetics, Inc. |
Complexes of inactivated pepsin fraction and heat shock protein
|
|
EP1945632B1
(en)
|
2005-11-08 |
2013-09-18 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic modulators of atp-binding cassette transporters
|
|
US20080039400A1
(en)
|
2006-01-24 |
2008-02-14 |
Universiteit Utrecht Uu Holding B.V. |
Treatment and prevention of inflammatory bowel diseases
|
|
NZ570103A
(en)
|
2006-01-26 |
2011-11-25 |
Foldrx Pharmaceuticals Inc |
Compounds and methods for modulating protein trafficking
|
|
WO2007137237A2
(en)
|
2006-05-19 |
2007-11-29 |
The Scripps Research Institute |
Treatment of protein misfolding
|
|
CA2656643C
(en)
|
2006-06-23 |
2015-08-25 |
Amicus Therapeutics, Inc. |
Method for the treatment of neurological disorders by enhancing the activity of .beta.-glucocerebrosidase
|
|
JP5599610B2
(ja)
|
2006-06-30 |
2014-10-01 |
スローン − ケッタリング インスティチュート フォー キャンサー リサーチ |
Ｈｓｐ９０の阻害による神経変性疾患の処置
|
|
US20080044390A1
(en)
|
2006-08-11 |
2008-02-21 |
Xiaowei Jin |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
CN101511872A
(zh)
|
2006-08-29 |
2009-08-19 |
为人技术株式会社 |
用于抑制凋亡的药物组合物及其递送方法
|
|
TW200831479A
(en)
*
|
2006-09-26 |
2008-08-01 |
Cytrx Corp |
Pharmaceutical compositions and methods for treating diseases
|
|
WO2008070010A2
(en)
|
2006-12-01 |
2008-06-12 |
Cytrx Corporation |
Hydroxylamine derivatives for the treatment of stroke
|
|
AU2008218109A1
(en)
|
2007-02-23 |
2008-08-28 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for treating glycogen storage diseases
|
|
WO2008112525A2
(en)
|
2007-03-09 |
2008-09-18 |
Link Medicine Corporation |
Treatment of lysosomal storage diseases
|
|
GB0705626D0
(en)
|
2007-03-23 |
2007-05-02 |
Royal Veterinary College |
Method for enhancing sperm survival
|
|
US20100168016A1
(en)
|
2007-04-11 |
2010-07-01 |
The Jackson Laboratory |
Diagnosis and treatment of diseases caused by misfolded proteins
|
|
WO2008128106A1
(en)
|
2007-04-13 |
2008-10-23 |
Amicus Therapeutics, Inc. |
Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
|
|
KR101540369B1
(ko)
|
2007-04-25 |
2015-07-29 |
사이토크로마 인코포레이티드 |
비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
|
|
US9056101B2
(en)
|
2007-04-26 |
2015-06-16 |
Amicus Therapeutics, Inc. |
Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
|
|
TW200901958A
(en)
|
2007-05-04 |
2009-01-16 |
Cytrx Corp |
Diabetic wound healing
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
|
EP2170361B1
(en)
|
2007-07-06 |
2016-05-25 |
Universiteit Utrecht Holding B.V. |
Treatment and prevention of inflammatory diseases and autoimmune diseases
|
|
EP2195333A1
(en)
|
2007-09-12 |
2010-06-16 |
Anaphore, Inc. |
Hsp70-based treatment for autoimmune diseases
|
|
US20100317690A1
(en)
|
2007-11-21 |
2010-12-16 |
Summit Corporation Plc |
Treatment of protein folding disorders
|
|
US8252789B2
(en)
|
2007-11-29 |
2012-08-28 |
Neuraltus Pharmaceuticals, Inc. |
Compositions and methods for treating lysosomal disorders
|
|
DK2247716T3
(da)
|
2008-01-30 |
2012-05-29 |
Geron Corp |
Syntetiske overflader til dyrkning af celler i kemisk defineret medie
|
|
WO2009095452A1
(en)
|
2008-01-31 |
2009-08-06 |
Crystax Pharmaceuticals, S.L. |
Crystal structure of the atpase domain of proteins of the hsp70 family
|
|
CA2712593A1
(en)
|
2008-02-01 |
2009-08-13 |
The Scripps Research Institute |
Methods for treating a condition characterized by dysfunction in protein homeostasis
|
|
AU2009244148B2
(en)
|
2008-05-07 |
2014-10-09 |
Biomarin Pharmaceutical Inc. |
Lysosomal targeting peptides and uses thereof
|
|
WO2009137796A2
(en)
|
2008-05-08 |
2009-11-12 |
Northwestern University |
Method of regulating the heat shock response
|
|
GB0809360D0
(en)
|
2008-05-22 |
2008-07-02 |
Isis Innovation |
Calcium modulation
|
|
EP3578195B1
(en)
|
2008-06-26 |
2023-08-09 |
Zevra Denmark A/S |
Use of hsp70 as a regulator of enzymatic activity
|
|
WO2010015816A2
(en)
|
2008-08-06 |
2010-02-11 |
Summit Corporation Plc |
Treatment of lysosomal storage disorders and other proteostatic diseases
|
|
WO2010022461A1
(en)
|
2008-08-29 |
2010-03-04 |
Children, Youth And Women's Health Service |
Sulphated sugars to increase activity of sulphatases en lysosomal storage disorders
|
|
KR20110063578A
(ko)
|
2008-09-29 |
2011-06-10 |
버텍스 파마슈티칼스 인코포레이티드 |
3－（6－（1－（2,2－디플루오로벤조［ｄ］［1,3］디옥솔－5－일）사이클로프로판카복스아미도）－3－메틸피리딘－2－일）벤조산의 투여 단위
|
|
WO2010053655A2
(en)
|
2008-11-07 |
2010-05-14 |
University Of Kansas |
Therapeutic methods with withaferin a and analogs
|
|
WO2010086418A1
(en)
|
2009-01-29 |
2010-08-05 |
Alfa Biogene International B.V. |
Functional food product comprising heat shock protein or a hydrolysate thereof
|
|
EP2218458A1
(en)
|
2009-02-13 |
2010-08-18 |
Fondazione Telethon |
Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
|
|
US8932571B2
(en)
|
2009-03-10 |
2015-01-13 |
Alfa Biogene International B.V. |
Skin care product
|
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
|
US8785168B2
(en)
|
2009-06-17 |
2014-07-22 |
Biomarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
|
MX344786B
(es)
|
2009-07-28 |
2017-01-06 |
Shire Human Genetic Therapies |
Composiciones y metodos para tratar enfermedad de gaucher.
|
|
WO2011019763A2
(en)
|
2009-08-10 |
2011-02-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
|
|
US20110081428A1
(en)
|
2009-09-16 |
2011-04-07 |
The Buck Institute For Age Research |
Use of thioflavin-like compounds to increase life span and/or health span
|
|
WO2011075686A2
(en)
|
2009-12-18 |
2011-06-23 |
Ventria Bioscience |
Methods & compositions comprising heat shock proteins
|
|
WO2012006329A2
(en)
*
|
2010-07-06 |
2012-01-12 |
Genomind, Llc |
Apoe4 and apoj biomarker-based prevention and treatment of dementia
|
|
US20130209549A1
(en)
|
2010-07-21 |
2013-08-15 |
University Of South Florida |
Materials and methods for treating neurodegenerative diseases
|
|
RU2013125923A
(ru)
|
2010-11-30 |
2015-01-10 |
Орфазиме Апс |
СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70
|
|
WO2013006076A1
(en)
|
2011-07-04 |
2013-01-10 |
New York University |
The use of intranasally administered hsp70 protein to treat neurodegenerative diseases
|
|
JP2015512913A
(ja)
|
2012-03-28 |
2015-04-30 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
グルコセレブロシダーゼ活性剤として有用なサリチル酸誘導体
|
|
CA2889990A1
(en)
*
|
2012-11-05 |
2014-05-08 |
Genzyme Corporation |
Compositions and methods for treating proteinopathies
|
|
EP2922874A4
(en)
|
2012-11-21 |
2016-10-19 |
Wuhan Yzy Biopharma Co Ltd |
BISPECIFIC ANTIBODIES
|
|
AU2015214358A1
(en)
*
|
2014-02-04 |
2016-08-18 |
New York University |
Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal storage diseases
|
|
HUE054957T2
(hu)
|
2014-09-15 |
2021-10-28 |
Orphazyme As |
Arimoklomol készítése
|
|
WO2016058000A1
(en)
*
|
2014-10-10 |
2016-04-14 |
Virginia Commonwealth University |
Oxygenated cholesterol sulfates for therapy of disorders caused by at least one of attenuated leptin activity and a lipid storage disorder
|